Privium Fund Management B.V. Arrowhead Pharmaceuticals, Inc. Transaction History
Privium Fund Management B.V.
- $354 Million
- Q2 2024
A detailed history of Privium Fund Management B.V. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 286,936 shares of ARWR stock, worth $5.63 Million. This represents 2.11% of its overall portfolio holdings.
Number of Shares
286,936
Previous 273,936
4.75%
Holding current value
$5.63 Million
Previous $7.83 Million
4.81%
% of portfolio
2.11%
Previous 2.32%
Shares
7 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$308 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$240 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$174 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$115 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$81.2 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.08B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...